Volume 32, Issue 1, Pages (October 2008)

Slides:



Advertisements
Similar presentations
Volume 133, Issue 1, Pages (July 2007)
Advertisements

Volume 68, Issue 4, Pages (October 2005)
Volume 54, Issue 4, Pages (May 2014)
Volume 18, Issue 6, Pages (December 2010)
Jaya Sahni, Andrew M. Scharenberg  Cell Metabolism 
Volume 133, Issue 1, Pages (July 2007)
Volume 11, Issue 4, Pages (April 2003)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Activation of the PKB/AKT Pathway by ICAM-2
Volume 33, Issue 2, Pages (January 2009)
Volume 28, Issue 3, Pages (September 2015)
Volume 18, Issue 17, Pages (September 2008)
Volume 22, Issue 5, Pages (May 2012)
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Volume 14, Issue 3, Pages (May 2004)
Volume 18, Issue 6, Pages (December 2010)
IRS1-Independent Defects Define Major Nodes of Insulin Resistance
Volume 64, Issue 2, Pages (August 2003)
Volume 137, Issue 5, Pages (May 2009)
Volume 68, Issue 2, Pages e6 (October 2017)
Volume 16, Issue 18, Pages (September 2006)
Stefanie S. Schalm, Diane C. Fingar, David M. Sabatini, John Blenis 
Volume 68, Issue 4, Pages (October 2005)
Volume 29, Issue 3, Pages (February 2008)
Sphingosine-1-phosphate–induced smooth muscle cell migration involves the mammalian target of rapamycin  William J. Tanski, MD, Suzanne M. Nicholl, PhD,
Volume 15, Issue 20, Pages (October 2005)
Sestrins Inhibit mTORC1 Kinase Activation through the GATOR Complex
SGK3 Mediates INPP4B-Dependent PI3K Signaling in Breast Cancer
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase
Volume 38, Issue 5, Pages (June 2010)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Ligand-Independent Recruitment of SRC-1 to Estrogen Receptor β through Phosphorylation of Activation Function AF-1  André Tremblay, Gilles B Tremblay,
Volume 53, Issue 4, Pages (February 2014)
Volume 127, Issue 1, Pages (October 2006)
Volume 25, Issue 2, Pages (April 2013)
Volume 45, Issue 6, Pages (March 2012)
Volume 27, Issue 6, Pages (September 2007)
Volume 10, Issue 1, Pages (July 2002)
Interleukin-6-Resistant Melanoma Cells Exhibit Reduced Activation of STAT3 and Lack of Inhibition of Cyclin E-Associated Kinase Activity  Markus Böhm,
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 116, Issue 6, Pages (June 1999)
Essential Role of TGF-β Signaling in Glucose-Induced Cell Hypertrophy
p38 MAPK activation is required for phosphorylation of Akt at Ser473.
Rsk1 mediates a MEK–MAP kinase cell survival signal
Volume 52, Issue 2, Pages (October 2013)
Mst1 Is an Interacting Protein that Mediates PHLPPs' Induced Apoptosis
Leila Khamzina, Philip A Gruppuso, Jack R Wands  Gastroenterology 
LAT Links the Pre-BCR to Calcium Signaling
Volume 18, Issue 4, Pages (April 2010)
Volume 129, Issue 2, Pages (April 2007)
Volume 59, Issue 3, Pages (March 2001)
John M Schmitt, Philip J.S Stork  Molecular Cell 
Volume 39, Issue 3, Pages (August 2010)
Yvonne Ng, Georg Ramm, Jamie A. Lopez, David E. James  Cell Metabolism 
Volume 32, Issue 1, Pages (October 2008)
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Brian K. Kennedy, Dudley W. Lamming  Cell Metabolism 
Leucine Signals to mTORC1 via Its Metabolite Acetyl-Coenzyme A
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Volume 34, Issue 6, Pages (June 2009)
Livio Trusolino, Andrea Bertotti, Paolo M Comoglio  Cell 
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Volume 2, Issue 2, Pages (August 2005)
Vidhya Ramachandran, Khyati H. Shah, Paul K. Herman  Molecular Cell 
RhoA GTPase Regulates B Cell Receptor Signaling
Phosphorylation and Functional Inactivation of TSC2 by Erk
Volume 57, Issue 2, Pages (January 2015)
Volume 58, Issue 3, Pages (May 2015)
Presentation transcript:

Volume 32, Issue 1, Pages 140-149 (October 2008) Syndecan-4 Regulates Subcellular Localization of mTOR Complex2 and Akt Activation in a PKCα-Dependent Manner in Endothelial Cells  Chohreh Partovian, Rong Ju, Zhen W. Zhuang, Kathleen A. Martin, Michael Simons  Molecular Cell  Volume 32, Issue 1, Pages 140-149 (October 2008) DOI: 10.1016/j.molcel.2008.09.010 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 Growth-Factor-Induced Akt Activation Is Decreased in the Absence of Syndecan-4 (A) Akt phosphorylation in response to FGF2 is decreased in S4−/− EC, while ERK phosphorylation is unchanged. (B) Quantitative analysis of P-Akt Ser473/total Akt: results represent the average of three different experiments performed in three different cell preparations. Results are means ± SEM. ∗p < 0.05. (C) Akt phosphorylation in response to VEGF or IGF1 stimulation. Note a decrease in S4−/− EC. (D) Akt phosphorylation in the lungs in response to FGF2 injected intraperitoneally in mice. Note a decrease in S4−/− mice. (E) In vitro Akt kinase assay performed using GSK-3 fusion protein as substrate: note decreased Akt activity in S4−/− EC. (F) Expression of syndecan-4 in S4−/− EC restores Akt phosphorylation: S4+/+ and S4−/− EC were transduced with adenoviruses encoding full-length HA-tagged syndecan-4 (Adeno-S4) or GFP (Adeno-GFP) used as a control. (G) Tyrosine-kinase-induced PI3-K activation is increased in S4−/− EC: phosphotyrosine was immunoprecipitated from whole-cell lysates and subjected to immunoblotting with an anti-p85 PI3-K antibody. (H) Western blotting of total cellular lysates contents from S4−/− and +/+ EC following treatment with phosphate-buffered saline (PBS) or FGF2 for components of the mTOR complex 2. (I) mTORC2 integrity is preserved in S4−/− EC: mSin-1 was immunoprecipitated from the total cell lysates of actively growing S4−/− and S4+/+ cells using a CHAPS-containing buffer and immunoblotted for mTOR, rictor, and mLST8. Molecular Cell 2008 32, 140-149DOI: (10.1016/j.molcel.2008.09.010) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 mTORC1 Activity Is Increased in S4−/− EC and Tissues (A) mTOR was immunoprecipitated from total cell lysates and immunoblotted with raptor, rictor, and mLST8: note the increased amount of raptor coimmunoprecipitated with mTOR in S4−/− EC. (B) Phosphorylation of p70S6K1 at Thr389 and S6RP at Ser235/236 in response to FGF2 is increased in S4−/− EC. Note similar levels of the mTORC1 components mLST8 and raptor between S4−/− and S4+/+ EC. (C) In vitro p70S6K1 kinase activity, performed using S6 ribosomal fusion GST peptide as substrate: note increased activity in S4−/− tissues. (D) Quantitative analysis of p70S6K1 activity assay in tissues from S4+/+ and S4−/− mice. Three mice in each group and results from different tissues were pooled in each group. Results are means ± SEM. ∗p < 0.05. (E) Immunoanalysis of 4E-BP1 and Akt phosphorylation. Rapamycin treatment inhibited FGF2-induced 4E-BP1 phosphorylation at Thr70 but did not restore Akt phosphorylation in S4−/− EC. (F) Immunoanalysis of raft domains isolated from S4−/− and S4+/+ EC. Note the decreased phosphorylation levels of Akt, mTOR, and PKCα as well as decreased levels of total PKCα, rictor, mLST8, and mSin-1 in S4−/− rafts. On the other hand, the levels of mTOR, PDK1, p70S6K, and P-S6RP are increased in S4−/− rafts. Molecular Cell 2008 32, 140-149DOI: (10.1016/j.molcel.2008.09.010) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 Syndecan-4 Regulates Akt Activation via PKCα-Dependent Translocation of Rictor, mSin-1, and mLST8 to Raft Domains (A) Immunoanalysis of FGF2 signaling in HUVEC. Note inhibition of Akt phosphorylation in the presence of Gö6976, an inhibitor of conventional PKCs, while PD98059, an inhibitor of MEK, or H89, a PKA inhibitor, did not affect Akt phosphorylation. (B) PKCα knockdown is associated with decreased FGF2-induced Akt phosphorylation inAB-1 cells, while ERK phosphorylation is maintained. (C) PKCα knockdown did not affect the expression levels of rictor, mSin-1, or mLST8 in total cell lysates of AB-1 cells. (D) PKCα knockdown in AB-1 EC is associated with decreased FGF2-induced Akt-Ser473 phosphorylation and decreased expression of rictor and mLST8 in plasma membrane rafts. Note the unchanged raptor level. (E) Immunoanalysis of raft domains isolated from S4−/− cells transduced with either myristoylated-PKCα (Ad-Myr-PKCα) or green fluorescent protein (Ad-GFP). Note the reappearance of rictor, mLST8, and mSin-1 in rafts of Myr-PKCα-transduced cells as well as increased Akt and mTOR phosphorylation. (F) Immunoanalysis of raft domains isolated from S4−/− cells transduced with either myristoylated-kinase-dead-PKCα (Ad-Myr-KD-PKCα) or green fluorescent protein (Ad-GFP): PKCα kinase activity is required for PKCα-mediated regulation of Akt and mTORC2. Molecular Cell 2008 32, 140-149DOI: (10.1016/j.molcel.2008.09.010) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 4 Decreased eNOS Activation, Increased Blood Pressure, and Also Smaller Endothelial Cell Size in S4−/− Mice (A) FGF2-induced-eNOS phosphorylation at Ser1179 is decreased in S4−/− EC. (B) eNOS activity in S4−/− EC: nitrite levels accumulated in the medium over 18 hr and expressed as pmoles of nitrate per mg of protein. Data are means ± SEM of six plates from two different cell preparations. (C) cGMP content of heart and lung tissues from S4−/− mice expressed as pmoles per mg of protein. Mean ± SEM; n = 3 mice per group. ∗p < 0.05. (D) Mean arterial blood pressure measured invasively in anesthetized animals is higher in S4−/− mice. Mean ± SEM; n = 4 mice per group. ∗p < 0.05. (E) FoxO1/3a and BAD phosphorylation in response to FGF2 stimulation in S4−/− EC. Tubulin was used as loading control. (F) Cell size of S4−/− versus S4+/+ EC. Serum-starved cells were harvested for analysis by flow cytometry. The mean FSC-H of G1-phase and CD31-positive cell population was determined in both S4+/+ (upper panels) and S4−/− (lower panels) EC. The mean FSC-H histogram curves for each cell type were shown separately and also overlapped (upper right panel). Note the shift to the left of the black curve, which corresponds to S4−/− cells. The bar graphs (lower right panel) show the quantification from two different experiments. Molecular Cell 2008 32, 140-149DOI: (10.1016/j.molcel.2008.09.010) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 5 A Proposed Model of S4/PKCα-Dependent Regulation of mTORC2 Localization in the Membrane Rafts and Akt Activation (A) Stimulation of S4+/+ EC with a heparin-binding growth factor induces tyrosine kinase receptor activation and syndecan-4 clustering. The former leads to PI3-K activation, increased concentration of PI(3,4,5)P3, and translocation of Akt to the rafts. The latter is associated with S4 shift to the rafts, formation of the S4-PI(4,5)P2 complex, and recruitment of PKCα. This in turn is associated with mSin-1, mLST8, and rictor translocation to the rafts and Akt phosphorylation, leading to phosphorylation of downstream targets such as eNOS. (B) In S4−/− EC, while Akt is still translocated to the membrane upon growth factor stimulation, its phosphorylation is impaired due to decreased levels of PKCα, rictor, mLST8, and mSin-1 in the rafts, which lead to decreased mTORC2 activity. mTOR shifts toward association with raptor, whose presence in the rafts is independent of the S4/PKCα complex. This leads to increased mTORC1 activity with increased p70S6K activation. Molecular Cell 2008 32, 140-149DOI: (10.1016/j.molcel.2008.09.010) Copyright © 2008 Elsevier Inc. Terms and Conditions